Literature DB >> 7686533

Cardiovascular responses to long-term blockade of nitric oxide synthesis.

R D Manning1, L Hu, H L Mizelle, J P Montani, M W Norton.   

Abstract

The goal of this study was to determine if there is a basal release of nitric oxide that affects long-term arterial pressure regulation in dogs. Studies were conducted over a 23-day period in eight conscious dogs with indwelling catheters. Nitric oxide synthesis was blocked by continuous intravenous infusion of nitro-L-arginine-methyl ester at 37.1 nmol/kg per minute for 11 days. Arterial pressure increased to 120 +/- 4% of control on the first day, decreased for a few days, and then increased to a maximum value of 122 +/- 6% of control on day 7. Bradycardia was sustained throughout the entire nitro-arginine period. Blockade of nitric oxide synthesis was evidenced by attenuated pressure and flow responses to systemic acetylcholine infusion. The pressor response to phenylephrine was increased for only 1 day, and the hypotensive effects of nitroprusside were enhanced. Also, the variability of arterial pressure was significantly increased during nitro-arginine. Sodium and water balances were positive the first day of nitro-arginine infusion but were unchanged for the entire nitro-arginine period. In conclusion, the data suggest that blockade of the basal release of nitric oxide in dogs causes an increase in the long-term level of arterial pressure without any sustained sodium or water retention.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686533     DOI: 10.1161/01.hyp.22.1.40

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension.

Authors:  Saowanee Nakmareong; Upa Kukongviriyapan; Poungrat Pakdeechote; Wanida Donpunha; Veerapol Kukongviriyapan; Bunkerd Kongyingyoes; Kwanjit Sompamit; Chada Phisalaphong
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-03-30       Impact factor: 3.000

2.  Role of nitric oxide in regulating cardiac electrophysiology.

Authors:  L Wang
Journal:  Exp Clin Cardiol       Date:  2001

3.  Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.

Authors:  P Soares-da-Silva; M Pestana; M A Vieira-Coelho; M H Fernandes; A Albino-Teixeira
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

Review 4.  Blood oxygen level-dependent MR imaging of the kidneys.

Authors:  Lu-Ping Li; Sarah Halter; Pottumarthi V Prasad
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

5.  Central and peripheral haemodynamic effects of L-NAME infusion in healthy volunteers.

Authors:  D R Morgan; B Silke; L J Dixon; P B Allen; C G Hanratty; G E McVeigh
Journal:  Eur J Clin Pharmacol       Date:  2003-05-17       Impact factor: 2.953

6.  Kidneys in hypertensive rats show reduced response to nitric oxide synthase inhibition as evaluated by BOLD MRI.

Authors:  Luping Li; Pippa Storey; David Kim; Wei Li; Pottumarthi Prasad
Journal:  J Magn Reson Imaging       Date:  2003-06       Impact factor: 4.813

7.  Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked.

Authors:  Tracy D Bell; Gerald F DiBona; Rachel Biemiller; Michael W Brands
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27

Review 8.  Endothelial dysfunction in experimental models of arterial hypertension: cause or consequence?

Authors:  Iveta Bernatova
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

Review 9.  Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies.

Authors:  Iveta Bernatova; Silvia Liskova
Journal:  Antioxidants (Basel)       Date:  2021-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.